VAERS reports by lot

GSK Varicella/Shingles lot TB2PK: VAERS reports

32 VAERS reports list lot TB2PK as a GSK Varicella/Shingles vaccine, received between 2019-09-09 and 2021-01-02. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
32
Reports
12%
Marked serious
0
With a death outcome
9
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)2623%
Injection-site / Local reaction1917%
Dermatological (non-injection-site)1816%
Musculoskeletal1614%
Gastrointestinal1110%
Neurological109%
Allergic / Anaphylactic55%
Psychiatric / Neuropsychiatric33%
Cardiac / Cardiovascular22%
Respiratory11%

Where reports came from

U.S. state of the reporter, where given (top 12).

Illinois4
Florida4
Michigan4
Texas2
New Jersey2
New Hampshire2
New York2
Oklahoma2
South Carolina1
Pennsylvania1
California1
Kansas1

Reports by month received

2019-0911
2019-1011
2019-113
2019-121
2020-011
2020-022
2020-041
2020-101
2021-011

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.